Life Science Leader1d
Where Are They Now? Tarsus Pharmaceuticals
Tarsus Pharmaceuticals is making a splash with Xdemvy, an eye drop that kills the demodex mites that cause inflammation and ...
FiercePharma2d
Amid takeover talk, SpringWorks scores FDA nod for rare genetic disease treatment Gomekli
Tuesday, the agency signed off on SpringWorks’ Gomekli (mirdametinib) as a treatment for the rare genetic disorder ...
Biomednewsbreaks - Quantum Biopharma Ltd. (NASDAQ: QNTM) Engages MZ Group For Investor Relations Strategy
Quantum BioPharma (NASDAQ: QNTM) has retained MZHCI, an MZ Group company, to lead its investor relations and financial communications efforts. The in ...
Quantum Biopharma Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
MZ will work closely with Quantum BioPharma management to develop and implement a comprehensive capital markets strategy designed to increase the Company’s visibility throughout the investment ...
Tesla's Bubble Still Going Strong -- Improving Fundamentals And Prospects
For now, Tesla's well-diversified capability across energy/storage/services are showing robust monetization opportunities ...
Tesla Is Losing Ground Against Its Biggest Rival in China
BYD makes advances in AI-powered driving software while Musk’s wait for approval grows.
Quantum Biopharma Engages Enterprise Canada and Empire Market Ventures to Lead Public Communications and Investor Awareness Programs
Empire is based at 40 Wall Street, New York, New York, United States of America. Empire has been engaged for a period of three months, effective February 7, 2025 (the “ Empire Agreement ”). Pursuant ...